We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals

16 hedge funds and large institutions have $9.19M invested in Armata Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$4.58M +$7.57M +8,277 New
BC
2
Broadfin Capital
New York
$2.18M +$3.6M +3,943 New
MP
3
MSD Partners
New York
$1.08M +$1.79M +1,954 New
AC
4
Armistice Capital
New York
$371K +$612K +670 New
PA
5
Perceptive Advisors
New York
$316K +$522K +571 New
RCM
6
RA Capital Management
Massachusetts
$257K +$425K +465 New
BGA
7
Belmont Global Advisors
Texas
$205K +$339K +371 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$69K +$115K +126 New
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$64K +$105K +115 New
Millennium Management
10
Millennium Management
New York
$40K +$66.7K +73 New
Morgan Stanley
11
Morgan Stanley
New York
$16K +$26.5K +29 New
Citigroup
12
Citigroup
New York
$6K +$10.1K +11 New
TWA
13
TCI Wealth Advisors
Arizona
$3K +$4.57K +5 New
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$3K +$5.49K +6 New
Walleye Trading
15
Walleye Trading
New York
$2K +$3.66K +4 New
TRCT
16
Tower Research Capital (TRC)
New York
$1K +$1.83K +2 New

ARMP Hedge Fund Activity: Q3 2015 in Review

16 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q3 2015, worth a combined $9.19M.

Buyers outnumbered sellers: 16 funds opened new ARMP positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Third Security, opening a new position worth an estimated $7.57M.

  • 16 institutional investors held Armata Pharmaceuticals (ARMP) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $9.19M of Armata Pharmaceuticals stock for Q3 2015.
  • 16 funds opened new Armata Pharmaceuticals positions in Q3 2015 and 0 closed out, a net change of +16 holders.
  • The largest Armata Pharmaceuticals buyer in Q3 2015 was Third Security, an estimated $7.57M added.

Based on aggregated 13F filings for Q3 2015.